Raynaud's Syndrome Completed Phase 2 Trials for Nitroglycerin (DB00727)

Also known as: Raynaud’s phenomenon / Raynaud's Phenomenon / Raynaud’s syndrome / Raynaud Syndrome / Raynaud / Raynaud's Disease / Raynaud phenomenon / Raynauds / Raynaud's syndrome NOS / Raynauds' phen / Raynaud Disease

IndicationStatusPhase
DBCOND0049133 (Raynaud's Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00480753Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's PhenomenonTreatment